|
Name |
2-Hexenoic acid, 2-methyl-
|
Molecular Formula | C7H12O2 | |
IUPAC Name* |
(E)-2-methylhex-2-enoic acid
|
|
SMILES |
CCC/C=C(\C)/C(=O)O
|
|
InChI |
InChI=1S/C7H12O2/c1-3-4-5-6(2)7(8)9/h5H,3-4H2,1-2H3,(H,8,9)/b6-5+
|
|
InChIKey |
AKOVMBAFZSPEQU-AATRIKPKSA-N
|
|
Synonyms |
2-Methyl-2-hexenoic acid; 28897-58-7; 2-Methylhex-2-enoic acid; 2-Hexenoic acid, 2-methyl-; (E)-2-methylhex-2-enoic acid; 2-methyl-2E-hexenoic acid; (E)-2-methyl-2-hexenoic acid; (2E)-2-Methylhex-2-Enoic Acid; 97961-66-5; 2-Hexenoic acid, 2-methyl-, (2E)-; EINECS 249-294-4; 2-Methylhex-2-enoicacid; SCHEMBL23310; SCHEMBL23311; DTXSID0067422; trans-2-methyl-hex-2-enoic acid; CHEBI:179470; ZINC2565970; (2E)-2-Methyl-2-hexenoic acid #; LMFA01020101; MFCD00015855; AKOS022633313; 2-Methyl-2-hexenoic acid, AldrichCPR; BS-53362; CS-0188277; M1147
|
|
CAS | 28897-58-7 | |
PubChem CID | 5282650 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 128.17 | ALogp: | 2.0 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 37.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 9 | QED Weighted: | 0.592 |
Caco-2 Permeability: | -4.523 | MDCK Permeability: | 0.00013100 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.004 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.001 |
30% Bioavailability (F30%): | 0.005 |
Blood-Brain-Barrier Penetration (BBB): | 0.977 | Plasma Protein Binding (PPB): | 80.11% |
Volume Distribution (VD): | 0.409 | Fu: | 28.19% |
CYP1A2-inhibitor: | 0.025 | CYP1A2-substrate: | 0.282 |
CYP2C19-inhibitor: | 0.026 | CYP2C19-substrate: | 0.201 |
CYP2C9-inhibitor: | 0.006 | CYP2C9-substrate: | 0.889 |
CYP2D6-inhibitor: | 0.013 | CYP2D6-substrate: | 0.195 |
CYP3A4-inhibitor: | 0.013 | CYP3A4-substrate: | 0.058 |
Clearance (CL): | 3.729 | Half-life (T1/2): | 0.881 |
hERG Blockers: | 0.003 | Human Hepatotoxicity (H-HT): | 0.1 |
Drug-inuced Liver Injury (DILI): | 0.064 | AMES Toxicity: | 0.003 |
Rat Oral Acute Toxicity: | 0.318 | Maximum Recommended Daily Dose: | 0.005 |
Skin Sensitization: | 0.153 | Carcinogencity: | 0.022 |
Eye Corrosion: | 0.985 | Eye Irritation: | 0.994 |
Respiratory Toxicity: | 0.114 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000879 | 0.481 | D0G4JI | 0.333 | ||||
ENC001586 | 0.419 | D04CRL | 0.292 | ||||
ENC004507 | 0.365 | D0Y3KG | 0.289 | ||||
ENC000018 | 0.357 | D06XGW | 0.231 | ||||
ENC005324 | 0.348 | D0ZK8H | 0.229 | ||||
ENC004866 | 0.348 | D02KJX | 0.229 | ||||
ENC001885 | 0.348 | D06VNK | 0.229 | ||||
ENC000061 | 0.333 | D0M1PQ | 0.225 | ||||
ENC002991 | 0.327 | D00WUF | 0.214 | ||||
ENC004509 | 0.326 | D0R9BG | 0.214 |